Published in Vaccine Weekly, April 13th, 2011
PPD is expected to provide a broad range of discovery, clinical development and post-approval services for drug and vaccine development. The company will strengthen local research capacities through program and site management, trial monitoring, specialized...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.